 |
Chlamydia and Gonorrhea Screening and Treatment
Facts:
- Over 7,500 cases of chlamydia infections were reported to the NM Department of Health in 2003.
- Chlamydia is the most common reportable disease in the US.
- Young teenagers and adults – ages 15 to 24 – have the highest rates of chlamydia infections.
- Most males and females with chlamydia infections have no symptoms.
- Chlamydia infection is the most common cause of pelvic inflammatory disease
which may lead to tubal infertility, ectopic pregnancies, and chronic pelvic pain in women.
- Accurate and cost effective nucleic acid amplification tests (NAATs) for diagnosing
chlamydia that can be performed on urine, urethral or cervical swabs are now readily available.
- The US Preventive Services Task Force, Center for
Disease Control and Prevention (CDC) and major medical organizations
including the AMA, American Academy of Pediatrics, and American Academy
of Obstetricians and Gynecologists all recommend routine annual
screening of
young sexually active women under 26 years of age for chlamydia.
- An important study has demonstrated that screening
women for chlamydia infection leads to a decrease in pelvic
inflammatory disease.
- Annual screening of women under age 26 is now a HEDIS
(Healthplan Employer Data and Information Set) measure for evaluating
the quality of care provided by managed care organizations.
Goal:
- To increase chlamydia screening of young, sexually active men and women in New Mexico.
- To improve the diagnosis, treatment and management of patients and their partners.
CPI Intervention:
- The Chlamydia Workgroup has produced a packet of
materials including a chlamydia screening guide, fact sheet, frequently
asked questions for providers, and a waiting room pamphlet for patient
education. The packet will be distributed to primary care physicians,
nurse practitioners, physician’s assistants, and mid-wives
throughout New Mexico.
- Members of the Workgroup will provide outreach to
primary care providers by offering presentations to provider groups
throughout New Mexico.
- The Workgroup will work closely with clinical laboratories, managed care organizations, and public health officials to
evaluate the impact of these educational activities on chlamydia testing and disease rates.
- The Workgroup will advocate for increasing provider options for the management of patients and their sexual contacts.
Resources
- New Mexico Clinical Prevention Initiative Chlamydia workgroup materials (June 2004):
- CDC Chlamydia Information http://www.cdc.gov/std/chlamydia/default.htm
- CDC Morbidity and Mortality Weekly Report, 2002 CDC STD Treatment Guidelines – May 10, 2002
http://www.cdc.gov/mmwr//preview/mmwrhtml/rr5106a1.htm
- National Committee for Quality Assurance (NCQA) – Chlamydia Screening in Women
http://www.ncqa.org/somc2001/chlamydia/somc_2001_chl.html
- The ABCs of Chlamydia
E-Learning Tool is a resource for clinicians contains the following six
interactive modules - the need for Chlamydia tests, Chlamydia
screening, approaching clients, lab
technologies, treatment, and client interaction.
http://www.cicatelli.org/ipp/whatsNEW.htm
- CDC Ready-to-Use STD Curriculum for Clinical
Educators…slide sets on Chlamydia, Gonorrhea, Herpes Simplex Virus, Human
Papilloma Virus, Syphilis, and Vaginitis:
http://www2a.cdc.gov/STDTraining/Ready-To-Use/userLogin.asp
- California Chlamydia Action Coalition http://www.ucsf.edu/castd/toolbox/
- California Chlamydia Action Coalition – A Guide to Sexual History Taking
http://www.ucsf.edu/castd/toolbox/08v2-Guide-SexHist_Taking.pdf
- CDC Sexually Transmitted Disease Prevention
- AIDS Education and Training Centers (AETC) National Resource Center – CDC Chlamydia Campaign http://www.aidsetc.org./aidsetc?page=et-14-00-04
- National Network of STD/HIV Prevention Training Centers
http://depts.washington.edu/nnptc/
Committee Chair: Bruce Trigg, MD
For further information, please contact
Annie Jung at cpi@nmms.org or 505-828-0237.
|
